Related Experiment Video
Updated: May 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
HDL cholesterol studies--more of the same?
1Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Pavilion Marguerite-D'Youville, 4th Floor, 2725 chemin Ste-Foy, Québec, QC G1V 4G5, Canada. jean-pierre.despres@criucpq.ulaval.ca
Abstract:
Studies published in 2012 in the field of HDL research have provided further evidence suggesting that a low HDL-cholesterol level, in the absence of related lipid or nonlipid risk factors, is not associated with increased risk of coronary heart disease.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Acute Coronary Syndrome III: Diagnostic Studies
